Amyris [NASDAQ: AMRS] revealed that the company is going to launch a new range of clean beauty products. The company is focusing on expanding its product range of consumer brands. The new range of Terasana branded products are concentrating on natural cannabinoids.
The company is concentrating on delivering clean beauty products devised with natural cannabinoids that offer highly efficient organic products directly to consumers. With this Amyris will further be able to expand its portfolio. Moreover, the company will also be able to expand its footprint in the clean beauty space.
Because of its exclusive lab to market synthetic biology platform, the company can develop and produce molecules from organically sourced sugarcane and a sustainable fermentation production. The company recently commercialized a CBG which is a fermentation-based non-psychoactive cannabinoid.
Earlier clinical studies suggest that the company CBG skincare application sourced from organic sugarcane is substantially better and provide better therapeutic impact and effectiveness compared to many other CBD topical applications. the CBD application address conditions like dry skin, irritation or redness on the skin, skin flaking, and blemishes.
John Melo president and CEO of Amyris said “ We’re very glad about the clinical results that demonstrate the benefits of CBG including the accelerated performance when it is combined with squalene. We’re optimistic about our future of clean beauty with cannabinoids and the efficiency they can bring to skincare. The company’s consumer business represents the fastest growing business in our portfolio. Moreover, it is approximately half of our product revenue”.